Janux Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Janux Therapeutics's balance sheet done over the years? Its assets were worth $380,407,000 last year, which is more than in the previous period. 9% of Janux Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $36,058,000, which means an decrease by -17% compared compared to last year.

Debt to Assets

Janux Therapeutics, Inc. (NASDAQ:JANX): Debt to assets
2019 679000 8.62M 1269.96%
2020 16217000 30.85M 190.26%
2021 379824000 13.49M 3.55%
2022 364010000 43.27M 11.89%
2023 380407000 36.05M 9.48%

JANX Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
19.20M51.42M35.58M7.81M658K
Short term investments
324.82M275.59M339.38M00
Net receivables
0700K200K8M0
Inventory
0-700K-200K00
Other current assets
5.21M5.42M2.05M249K0
Total current assets
349.24M332.43M377.01M16.06M658K
Non-current assets:
Property, Plant and Equipment
27.84M29.36M1.59M155K21K
Goodwill
00000
Intangible assets
00000
Long term investments
0816K816K00
Other non-current assets
3.32M1.39M392K-155K-21K
Total non-current assets
31.16M31.57M2.80M155K21K
Total assets
380.40M364.01M379.82M16.21M679K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1.70M5.40M5.16M1.95M0
Short term debt
3.03M763K194K751K4M
Total current liabilities
13.03M16.50M12.79M3.18M4.62M
Non-current liabilities:
Long term debt
23.02M24.54M003.99M
Deferred tax
00000
Other non-current liabilities
02.22M021.62M0
Total non-current liabilities
23.02M26.76M700K27.67M3.99M
Total liabilities
36.05M43.27M13.49M30.85M8.62M
Data sourceData sourceData source